RxDoctor Payments Data

Gilbert Kliman

Ophthalmology · Menlo Park, CANPI 1578771671

Payments from drug & device makers

What this record shows

The money is spread across several categories — ownership interests (43.2%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Glaukos Corporation accounts for 99.9% of it on its own, with 4 other manufacturers making up the rest. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,522,731in general payments, 2019–2025

Across 49 payments — averaging $31,076 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Glaukos Corporation$1.5M
  • Carl Zeiss Meditec, Inc.$523
  • Alcon$278
  • Johnson & Johnson Surgical Vision, Inc.$171
  • Johnson & Johnson Vision Care, Inc.$31

What the payments were for

  • Royalty or licence$428,98928%
  • Consulting fees$90,0006%
  • Speaking & faculty fees$331,50022%
  • Travel & lodging$13,8201%
  • Food & beverage$1,1230%
  • Ownership interest$657,29943%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,522,731 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California →

Other ophthalmology in Menlo Park

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →